1 | predictor | 6,864 |
2 | determinant | 1,436 |
3 | discriminator | 61 |
4 | prognosticator | 41 |
5 | predicator | 4 |
6 | displacer | 3 |
7 | codeterminant | 2 |
8 | determinants/predictors | 2 |
9 | mis-calibration | 2 |
10 | 3'-o-tetraphosphates | 1 |
11 | 3-amino-1-carbamo-thioyl-5- | 1 |
12 | adverse-effect-level | 1 |
13 | ae-profile | 1 |
14 | ameliorament | 1 |
15 | codeterminants | 1 |
16 | community-functioning | 1 |
17 | corrosion/oxidation | 1 |
18 | depositories | 1 |
19 | determinanats | 1 |
20 | ester-lipid | 1 |
21 | evaluators/1 | 1 |
22 | explanator | 1 |
23 | f-statistics | 1 |
24 | fit-model | 1 |
25 | fungus-infections | 1 |
26 | inhibition/reversal | 1 |
27 | insulin-sensitisers | 1 |
28 | inter-belt | 1 |
29 | lewis-base | 1 |
30 | miscategorizations | 1 |
31 | orchestrators | 1 |
32 | outgassing | 1 |
33 | ph-dependency | 1 |
34 | potentiations | 1 |
35 | predictorsqbetween | 1 |
36 | propane-1,3-di-ammonium | 1 |
37 | risk-indicator | 1 |
38 | samples.clinicaltrials.gov | 1 |
39 | sub-discipline | 1 |
40 | symptom/event | 1 |
41 | typs | 1 |
42 | under-usage | 1 |
43 | within-panel | 1 |
1 | 3'-o-tetraphosphates | 1 |
2 | 3-amino-1-carbamo-thioyl-5- | 1 |
3 | adverse-effect-level | 1 |
4 | ae-profile | 1 |
5 | ameliorament | 1 |
6 | codeterminant | 2 |
7 | codeterminants | 1 |
8 | community-functioning | 1 |
9 | corrosion/oxidation | 1 |
10 | depositories | 1 |
11 | determinanats | 1 |
12 | determinant | 1,436 |
13 | determinants/predictors | 2 |
14 | discriminator | 61 |
15 | displacer | 3 |
16 | ester-lipid | 1 |
17 | evaluators/1 | 1 |
18 | explanator | 1 |
19 | f-statistics | 1 |
20 | fit-model | 1 |
21 | fungus-infections | 1 |
22 | inhibition/reversal | 1 |
23 | insulin-sensitisers | 1 |
24 | inter-belt | 1 |
25 | lewis-base | 1 |
26 | mis-calibration | 2 |
27 | miscategorizations | 1 |
28 | orchestrators | 1 |
29 | outgassing | 1 |
30 | ph-dependency | 1 |
31 | potentiations | 1 |
32 | predicator | 4 |
33 | predictor | 6,864 |
34 | predictorsqbetween | 1 |
35 | prognosticator | 41 |
36 | propane-1,3-di-ammonium | 1 |
37 | risk-indicator | 1 |
38 | samples.clinicaltrials.gov | 1 |
39 | sub-discipline | 1 |
40 | symptom/event | 1 |
41 | typs | 1 |
42 | under-usage | 1 |
43 | within-panel | 1 |
1 | 3-amino-1-carbamo-thioyl-5- | 1 |
2 | evaluators/1 | 1 |
3 | ester-lipid | 1 |
4 | under-usage | 1 |
5 | ae-profile | 1 |
6 | sub-discipline | 1 |
7 | lewis-base | 1 |
8 | community-functioning | 1 |
9 | outgassing | 1 |
10 | inhibition/reversal | 1 |
11 | fit-model | 1 |
12 | within-panel | 1 |
13 | adverse-effect-level | 1 |
14 | propane-1,3-di-ammonium | 1 |
15 | predictorsqbetween | 1 |
16 | corrosion/oxidation | 1 |
17 | mis-calibration | 2 |
18 | displacer | 3 |
19 | predicator | 4 |
20 | risk-indicator | 1 |
21 | prognosticator | 41 |
22 | explanator | 1 |
23 | discriminator | 61 |
24 | predictor | 6,864 |
25 | f-statistics | 1 |
26 | depositories | 1 |
27 | 3'-o-tetraphosphates | 1 |
28 | potentiations | 1 |
29 | miscategorizations | 1 |
30 | fungus-infections | 1 |
31 | typs | 1 |
32 | insulin-sensitisers | 1 |
33 | orchestrators | 1 |
34 | determinants/predictors | 2 |
35 | determinanats | 1 |
36 | codeterminants | 1 |
37 | inter-belt | 1 |
38 | determinant | 1,436 |
39 | codeterminant | 2 |
40 | ameliorament | 1 |
41 | symptom/event | 1 |
42 | samples.clinicaltrials.gov | 1 |
43 | ph-dependency | 1 |